Develop Health vs Infinx
Two Prior Authorization vendors, side by side. Facts from public sources; judgments are ours.
At a glance
Derived from public facts · a rough scale, not a ranking
| Develop Health | Infinx | |
|---|---|---|
| Pricing model | Free to providers (funded by payers/pharma) · pharma-funded, free for prescribers | Enterprise contract (custom) · Software plus services, quote-based |
| Speed to go live | API integration into existing EHR workflow | Standard EHR integration project |
| Automation model | Autonomous agents · automated benefit checks and PA submission | Tech-enabled service · AI agents plus expert staff |
| Built for | Small practices, Mid-size groups, Enterprise systems | Mid-size groups, Enterprise systems, Billing companies |
| Security posture | HIPAA | HITRUST, SOC 2 Type II, HIPAA |
| Company maturity | 4 yrs (est. 2022) | 14 yrs (est. 2012) |
| Financial backing | $17.6M · Series A | $186M reported · Growth (KKR minority stake 2024) |
| Named customers | 4 named | None public |
| Published results | No public numbers | No public numbers |
| Documented integrations | 2 listed | 5 listed |
| Third-party validation | None found | None found |
Bottom line
- Pick Develop Health if medication prior auths bottleneck your prescribers and you want end-to-end PA automation at no cost to the practice.
- Pick Infinx if you want prior auth and revenue cycle work handled by a blend of AI and human specialists rather than buying software your staff must run.
Develop Health
AI benefit verification and prior auth for prescriptions
- Founded
- 2022
- HQ
- Menlo Park, CA
- Stage
- Series A
- Raised
- $17.6M
What it does
- Real-time benefit verification with plan-specific cost and coverage
- Predicts coverage and PA requirements at point of prescription
- Generates and submits prescription prior authorization packages
- Drafts appeals and manages denials automatically
- Returns structured coverage data into the prescriber's EHR
Where it's strong
- Purpose-built for prescription drug access (benefit checks plus medication PA), a narrower and deeper wedge than general prior auth vendors.
- Named traction with high-volume telehealth prescribers like Ro and LifeMD, where GLP-1 coverage friction makes the ROI easy to measure.
- Founders came from Canvas Medical and Rupa Health, so the product is built around real prescriber workflow integration rather than a standalone portal.
What buyers should weigh
- Total funding of $17.6 million and a 2022 founding date make this an early-stage vendor bet; assess team depth and support model before committing core volume.
- Public proof points are concentrated in telehealth and virtual care companies, so traditional health systems and pharmacies will find fewer reference customers.
- Scope is medications only; if you also need procedure, imaging, or DME prior auth, you will still need another vendor.
Named customers
Ro · LifeMD · Calibrate · Sunrise
Integrations
Infinx
AI plus specialists for prior auth and patient access
- Founded
- 2012
- HQ
- San Jose, CA
- Stage
- Growth (KKR minority stake 2024)
- Raised
- $186M reported
What it does
- AI prior authorization determination, submission, and status tracking
- Eligibility verification and benefits checks in one platform
- Patient pay estimates before service
- Certified specialists work exceptions automation cannot resolve
- AR recovery and denial management services
Where it's strong
- The AI-plus-human model delivers completed authorizations, not just software your staff still has to work.
- Deep roots in high-volume prior auth specialties like radiology, labs, and cardiology.
- Trusted by more than 900 provider organizations, with KKR and Norwest backing.
What buyers should weigh
- Part of the value is outsourced labor, so compare its per-transaction economics against pure software options.
- Named customer references are rare in public materials; case studies are anonymized.
- Broad service catalog means implementation scope needs careful definition up front.
Integrations
Compare against the rest of Prior Authorization
Deciding between these two?
First Pass tracks Prior Authorization every week: funding, launches, and what changed since this page was written.